BioNTech SE BNTX Cash Flow Statement (2018-2026)

NASDAQ BNTX
$87.11 -0.40 (-0.45%)
As of: Nov 10, 2026 · 12:24 PM EST
Reported Financials

BioNTech SE Quarterly Cash Flow Statement

Periods 33 quarters
Latest Sep 2026

BioNTech SE reported cash from operations of -$0.15B and free cash flow of -$0.11B for the quarter ended Sep 2026, down 116.4% year over year. This cash flow statement covers 33 quarters of results from Sep 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
3,622.04M4,151.30M1,784.12M1,799.67M2,324.84M539.03M-207.33M174.83M492.67M-342.31M-869.91M217.56M277.30M-437.37M-437.62M-33.55M-355.03M-622.72M-954.07M212.25M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
29.74M30.98M35.43M33.78M29.59M33.70M34.74M44.96M84.78M41.61M53.74M48.76M176.75M45.02M57.73M145.20M191.83M142.01M309.30M382.29M
Share-based CompensationStock Comp.
23.45M12.57M15.79M61.91M22.65M9.23M14.26M16.87M15.28M17.71M21.75M44.92M25.11M23.25M36.34M32.62M28.05M26.69M24.29M23.01M
Cash from Discontinued OperationsCash from Discont. Ops
-228.22M4,545.69M4,181.90M4,818.44M845.99M-727.08M4,776.78M883.06M915.52M-344.70M1,752.31M-701.65M-495.08M-821.21M165.83M912.68M360.27M-492.88M12.20M-149.33M
Gains from Sales and DivestituresGains Divest
4.80M0.21M0.20M0.20M0.21M0.11M3.59M0.22M-0.22M-0.11M-0.11M-0.34M-1.52M-0.93M-0.12M-1.05M-0.12M
Gains from Investment SecuritiesGains Investment
-2.32M-329.85M81.79M-22.81M1.85M
Other non-cash itemsOther Non-Cash
-105.25M6.85M-367.71M117.16M864.97M56.99M-432.30M167.97M71.33M190.55M172.73M162.76M-34.30M93.30M13.81M-28.17M-50.05M0.47M20.11M-3.68M
Change in Working Capital
Change in ReceivablesChange Receivables
-1,959.28M-452.86M3,387.69M2,263.98M-659.90M959.35M687.12M4,451.16M1,722.59M-911.74M-940.26M589.75M1,030.76M94.29M501.09M-562.67M
Change in InventoryChange Inventory
-124.81M48.48M97.74M73.50M-147.73M16.64M-27.01M36.14M62.40M13.36M5.71M40.63M21.27M35.55M25.81M5.96M135.26M8.20M3.72M38.54M
Change in Accrued ExpensesChange Accrued Exp.
Change in Other Operating LiabilitiesOther Liabilities Change
-3.22M5.81M-9.89M-3.34M-16.03M-5.02M-15.25M-20.94M-12.28M-22.70M
Other Working Capital ChangesOther WC Changes
37.06M-2.13M92.30M-2.32M-329.85M81.79M135.03M-3.81M-22.81M1.85M5.38M-6.59M4.17M-11.89M-19.58M18.35M2.91M
Other Operating Activities (as filed)
0.23M0.79M1.60M4.34M23.26M57.53M46.28M76.53M98.77M216.62M87.01M80.28M129.94M124.75M82.75M97.62M71.94M101.39M82.30M89.73M
Cash from OperationsCash from Ops.
-228.22M4,545.69M4,181.90M4,818.44M845.99M-727.08M4,776.78M883.06M915.52M-344.70M1,752.31M-701.65M-495.08M-821.21M165.83M912.68M360.27M-492.88M12.20M-149.33M
Investing Activities
Capital ExpendituresCapex
-45.07M-49.50M-75.33M-78.54M-139.37M-48.52M-73.18M-57.91M-90.16M-63.55M-95.41M-79.95M-71.17M-51.44M-30.68M-41.97M-73.57M-66.50M-63.46M-38.65M
Sales of Property, Plant and EquipmentPP&E (Sale)
2.29M0.40M0.20M-0.87M0.11M0.22M0.33M0.75M0.53M0.57M3.39M0.70M1.87M3.95M1.73M
Change in Property, Plant and EquipmentChange in PP&E
47.36M49.50M75.33M78.95M139.57M48.52M73.18M57.04M90.27M63.55M95.63M80.28M71.92M51.96M31.24M45.36M74.27M68.37M67.42M40.38M
Change in IntangiblesChange Intangibless
-16.02M-18.74M-5.12M-4.74M-8.06M-10.30M-263.63M-105.81M-114.59M-85.17M-56.75M-11.20M-26.18M-598.73M-3.51M-3.16M1.28M-25.87M-0.93M-17.14M
Acquisitions
-23.79M-366.75M724.97M-82.57M308.24M-36.58M
Net of Acquisitions & DivestmentsNet Acquisitions
23.79M366.75M-724.97M82.57M-308.24M36.58M
Purchase of InvestmentsInvestments Purchased
-22.31M-28.81M-1.11M-17.04M
Other Investing Activities (as filed)Other investing (as filed)
-114.28M322.56M-83.66M-83.99M-128.25M-789.34M-2,495.60M-1,341.36M4,582.86M9.99M35.32M66.66M3.53M24.40M8.83M8.18M43.19M16.74M39.17M18.75M
Cash from Investing ActivitiesCash from Investing
-114.28M322.56M-83.66M-83.99M-164.26M-789.34M-2,495.60M-1,341.36M-2,899.77M-2,503.41M-259.96M-156.06M648.32M1,311.49M-72.90M-1,081.73M-3,172.72M3,103.18M-116.35M929.20M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.21M0.40M0.20M0.11M0.22M44.96M43.94M60.86M
Long-Term Debt RepaymentsLT Debt Repayment
-58.00M-21.10M-18.96M38.36M-1,829.08M-0.11M1,833.51M-2,856.59M-2.48M4.92M-4.73M-4.19M-1.40M-10.01M-0.12M-6.74M
Net Long-Term Debt Issued (Repaid)Net LT Debt
58.00M21.10M0.21M19.36M-38.16M1,829.08M0.22M-1,833.29M2,856.59M2.48M-4.92M4.73M4.19M1.40M10.01M45.07M50.68M60.86M
Net Debt Issuances and RepaymentsNet Debt Issuance
58.00M21.10M0.21M19.36M-38.16M1,829.08M0.22M-1,833.29M2,856.59M2.48M-4.92M4.73M4.19M1.40M10.01M45.07M50.68M60.86M
Change in Capital Stock
Common Stock IssuedStock Issued
165.88M124.02M4.80M111.41M64.68M1.09M0.43M
Shares Repurchased
-306.14M-649.13M-56.83M-302.68M-167.69M-328.43M-0.86M-150.18M-315.56M
Net Shares Issued and RepurchasedNet Shares Issued
165.88M124.02M310.94M760.54M121.51M302.68M167.69M329.52M1.29M150.18M315.56M
Net Equity Issued and RepurchasedNet Equity Issued
165.88M124.02M310.94M760.54M121.51M302.68M167.69M329.52M1.29M150.18M315.56M
Dividend Payments
Dividends Paid - Common and PreferredDiv Paid (Total)
-516.78M-488.31M988.21M
Cash from Financing ActivitiesCash from Financing
-55.94M90.12M-833.90M-658.81M-66.01M-312.66M-177.93M-338.55M-13.88M-8.47M-24.66M-8.68M-7.80M-14.52M-15.06M-13.44M-16.65M30.91M-126.12M-267.59M
Additional items
Exchange Rate EffectFX Effect
17.62M60.05M118.98M47.09M-154.67M-29.09M99.31M66.62M-16.57M7.39M-3.55M-2.53M14.53M-16.94M10.41M-25.13M1.63M-3.98M-3.84M2.30M
Change in Cash
-818.40M4,958.38M3,264.34M4,075.65M615.72M-1,829.08M2,103.26M-796.85M-1,998.13M-2,856.59M1,467.69M-866.39M145.44M475.77M77.88M-182.49M-2,829.09M2,641.20M-230.26M512.28M
Ending Cash Balance
13,221.97M6,880.27M9,751.68M13,194.90M7,524.47M13,242.50M15,396.30M14,254.87M827.02M9,689.77M11,111.86M10,750.50M254.12M11,024.05M12,043.51M11,840.43M852.85M11,390.56M11,126.21M11,568.55M
Free Cash FlowFCF
-183.15M4,595.19M4,257.24M4,896.99M985.35M-678.57M4,849.96M940.98M1,005.68M-281.15M1,847.72M-621.70M-423.91M-769.77M196.51M954.65M433.84M-426.39M75.67M-110.67M
Net Cash FlowNCF
-398.45M4,958.38M3,264.34M4,075.65M615.72M-1,829.08M2,103.26M-796.85M-1,998.13M-2,856.59M1,467.69M-866.39M145.44M475.77M77.88M-182.49M-2,829.09M2,641.20M-230.26M512.28M
Interest Paid
-6.98M-7.18M-6.19M-4.34M-5.10M-1.29M-1.42M-1.31M9.79M
Income Taxes PaidTaxes Paid
1,770.52M1,480.70M690.71M664.65M1,628.62M220.57M-241.52M72.72M220.89M-18.14M2.15M-43.27M44.56M-31.14M-18.22M62.43M90.33M-42.38M-44.05M43.14M

BioNTech SE Cash Flow Statement API

Pull BioNTech SE's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BNTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY